Clinical Efficacy Observation of Bromfenac Sodium Eye Drops in the Treatment of Xerophthalmia / 中国药房
China Pharmacy
; (12): 4145-4146,4147, 2016.
Article
em Zh
| WPRIM
| ID: wpr-605471
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE:
To observe the clinical efficacy and safety of Bromfenac sodium eyed drops in the treatment of xe-rophthalmia.METHODS:
80 patients with xerophthalmia were randomly divided into observation group and control group,with 40 cases in each group. Control group was given 0.1% Sodium hyaluronate,one drop,qd;observation group was given 0.1% Sodi-um hyaluronate eye drops,one drop,bid. Both groups received 14 d of treatment. The subjective symptom and sign,the time of lacrimal film break-up,fluorescent staining score and schemer test were observed in 2 groups before treatment,3,7,14 d after treatment. Clinical efficacy and the occurrence of ADR were observed in 2 groups.RESULTS:
There was no statistical significance in subjective symptom and sign,the time of lacrimal film break-up,fluorescent staining score and tear between 2 groups before treatment,3,7 d after treatment(P>0.05). 14 d after treatment,subjective symptom and sign and fluorescent staining score of 2 groups were decreased significantly,and the time of lacrimal film break-up was prolonged and secretion was increased significant-ly;the observation group was significantly better than the control group,with statistical significance (P0.05).CONCLUSIONS:
Sodium hyaluronate eye drops is effective for xerophthalmia,and can relieve the symptoms with good safety.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
China Pharmacy
Ano de publicação:
2016
Tipo de documento:
Article